Based on the phenotypic alterations of CRC-NK cells, we assayed the NK cell degranulation potential (CD107a surface expression) and IFN-γ production in response to challenge by K562 cells as canonical target. The gene discussed is LAMP1; the disease is colorectal carcinoma.